Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(28 sites)

United States

Molecure Investigative Site, Birmingham, Alabama

Molecure Investigative Site, Kansas City, Kansas

Molecure Investigative Site, Baltimore, Maryland

Molecure Investigative Site, Rochester, Minnesota

Molecure Investigative Site, Cleveland, Ohio

Molecure Investigative Site, Philadelphia, Pennsylvania

Molecure Investigative Site, Charleston, South Carolina

Denmark

Molecure Investigative Site, Vejle

France

Molecure Investigative Site, Bobigny

Molecure Investigative Site, Montpellier

Molecure Investigative Site, Paris

Germany

Molecure Investigative Site, Essen

Molecure Investigative Site, Freiburg im Breisgau

Molecure Investigative Site, Mainz-GE

Greece

Molecure Investigative Site, Corfu

Molecure Investigative Site, Heraklion

Molecure Investigative Site, Pátrai

Molecure Investigative Site, Thessaloniki

Netherlands

Molecure Investigative Site, Nieuwegein

Molecure Investigative Site, Rotterdam

Norway

Molecure Investigative Site, Bergen

Molecure Investigative Site, Oslo

United Kingdom

Molecure Investigative Site, Birmingham

Molecure Investigative Site, Cambridge

Molecure Investigative Site, Edinburgh

Molecure Investigative Site, London